Skip to main content

Asuragen Licenses MicroRNA IP From Rockefeller University

NEW YORK (GenomeWeb News) – Asuragen licensed microRNA sequences from Rockefeller University to develop early cancer detection tools, the company said today.
 
Under the semi-exclusive agreement, Asuragen will have access to microRNAs identified by a group led by Thomas Tuschl. These microRNAs are involved with human diseases like diabetes and cancer.
 
Financial details were not disclosed.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.